NCT04703842View on ClinicalTrials.gov

Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

September 23, 2021

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2028

Conditions
Congestive Heart FailureHeart Failure, SystolicHeart FailureHFrEF - Heart Failure With Reduced Ejection Fraction
Interventions
BIOLOGICAL

SRD-001

AAV1/SERCA2a

DRUG

Placebo

SRD-001 matching placebo

Trial Locations (5)

63110

RECRUITING

Washington University in Saint Louis, St Louis

75390

RECRUITING

University of Texas Southwestern Medical Center, Dallas

92123

RECRUITING

San Diego Cardiac Center, San Diego

94143

RECRUITING

University of California, San Francisco, San Francisco

98195

RECRUITING

University of Washington Medicine, Seattle

All Listed Sponsors
lead

Sardocor Corp.

INDUSTRY